Quest Diagnostics (DGX) P/E (2009 - 2026)
Quest Diagnostics (DGX) P/E from Jun 30, 2009 to Jul 21, 2026. The TTM Quest Diagnostics (DGX) P/E is 23.02. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Quest Diagnostics (DGX)
| Year | P/E | Change |
|---|---|---|
| 2026 | 23.02 | +15.50% |
| 2025 | 19.93 | +3.56% |
| 2024 | 19.25 | +13.32% |
| 2023 | 16.99 | +22.64% |
| 2022 | 13.85 | +35.18% |
| 2021 | 10.24 | -31.92% |
| 2020 | 15.05 | -14.65% |
| 2019 | 17.63 | +19.70% |
| 2018 | 14.73 | -22.79% |
| 2017 | 19.08 | +21.71% |
| 2016 | 15.68 | -0.67% |
| 2015 | 15.78 | +23.23% |
| 2014 | 12.81 | +35.60% |
| 2013 | 9.44 | -31.24% |
| 2012 | 13.73 | -30.59% |
| 2011 | 19.79 | +52.93% |
| 2010 | 12.94 | -55.98% |
| 2009 | 29.39 | N/A |
Comparison Quest Diagnostics (DGX) P/E with competitors
Quest Diagnostics (DGX) P/E is 23.02.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -95.45% |
| MBAI | CheckCap Ltd | 1.71 | -92.56% |
| FONR | Fonar Corp | 15.48 | -32.78% |
| QGEN | Qiagen NV | 20.03 | -13.01% |
| LH | Laboratory Corp Of America Holdings | 23.87 | +3.68% |
| IQV | IQVIA Holdings Inc | 25.28 | +9.81% |
| A | Agilent Technologies Inc | 26.96 | +17.08% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | +36.94% |
| MTD | Mettler-Toledo International Inc | 32.45 | +40.94% |
| MEDP | Medpace Holdings Inc | 32.55 | +41.37% |
| IDXX | Idexx Laboratories Inc | 40.58 | +76.23% |
| ILMN | Illumina Inc | 44.12 | +91.62% |
| RVTY | Revvity Inc | 52.68 | +128.80% |
| VCYT | Veracyte Inc | 53.71 | +133.28% |
| ICLR | Icon Plc | 57.45 | +149.52% |
| SHC | Sotera Health Company | 74.08 | +221.76% |
| WAT | Waters Corp | 102.79 | +346.42% |